In human tissue, overall IL‐1R1 expression was faint in hepatocytes and more visible in immune cells – in particular macrophages – in the liver – with no apparent difference between NAFLD and NASH cases using immunohistochemistry (Figure S11A,B). Here, IL1R1 is linked to metabolic dysfunction-associated steatohepatitis.